The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.
about
Electrochemistry of nonconjugated proteins and glycoproteins. Toward sensors for biomedicine and glycomicsReducing synuclein accumulation improves neuronal survival after spinal cord injuryMolecular ageing of alpha- and Beta-synucleins: protein damage and repair mechanisms.Parkinson's disease dementia and potential therapeutic strategies.α-Synuclein elevation in human neurodegenerative diseases: experimental, pathogenetic, and therapeutic implications.Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations.
P2860
The therapeutical potential of alpha-synuclein antiaggregatory agents for dementia with Lewy bodies.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
The therapeutical potential of ...... for dementia with Lewy bodies.
@en
The therapeutical potential of ...... for dementia with Lewy bodies.
@nl
type
label
The therapeutical potential of ...... for dementia with Lewy bodies.
@en
The therapeutical potential of ...... for dementia with Lewy bodies.
@nl
prefLabel
The therapeutical potential of ...... for dementia with Lewy bodies.
@en
The therapeutical potential of ...... for dementia with Lewy bodies.
@nl
P1476
The therapeutical potential of ...... for dementia with Lewy bodies
@en
P2093
Aurelio Ariza
P304
P356
10.2174/092986708786242868
P50
P577
2008-01-01T00:00:00Z